ReviewDisease models & mechanisms2026
Disease modelling with in vitro vascularised organoids.
Review in Disease models & mechanisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Enhancing the in vitro architecture of human disease.Disease models & mechanisms · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Organoids are 3D systems derived from stem cells that recapitulate human tissue microenvironments, offering a useful tool for a wide range of investigations, including developmental biology, drug screening and disease modelling. As the vasculature is critical in biological processes within the human body, both in health and disease, recent efforts in the field have focused on developing vascularised organoids. In this At a Glance article, we discuss a number of currently available vasculature fabrication approaches, including co-culture with vascular endothelial cells, assembloids, co-differentiation, genetic engineering, 3D bioprinting and organ-on-a-chip systems, along with their advantages and limitations. We also provide a comparison of these fabrication approaches and their use for modelling diseases. Finally, we discuss current challenges and future directions regarding the use of vascularised organoids to mimic human physiological conditions and as clinically relevant models of human diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.